Podcast: US FDA’s ‘Within Label’ Definition Allows Companies To Elaborate On Indications
Executive Summary
Permitted speech for approved products could shift dramatically depending on how hard a Trump FDA Commissioner pushes, but the expansion at the end of the Obama Administration is a significant step in its own right – one that former Commissioner Rob Califf emphasizes in an interview that is also available as a podcast.